PL144899B1 - Method of obtaining novel triazine derivatives - Google Patents

Method of obtaining novel triazine derivatives Download PDF

Info

Publication number
PL144899B1
PL144899B1 PL1984250213A PL25021384A PL144899B1 PL 144899 B1 PL144899 B1 PL 144899B1 PL 1984250213 A PL1984250213 A PL 1984250213A PL 25021384 A PL25021384 A PL 25021384A PL 144899 B1 PL144899 B1 PL 144899B1
Authority
PL
Poland
Prior art keywords
groups
formula
alkyl
halogen
aryl
Prior art date
Application number
PL1984250213A
Other languages
English (en)
Other versions
PL250213A1 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PL250213A1 publication Critical patent/PL250213A1/xx
Publication of PL144899B1 publication Critical patent/PL144899B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (4)

1. Zastrzezenia patentowe 1. Sposób wytwarzania nowych pochodnych triazyny o ogólnym wzorze 6# w którym R o- znacza grupe C1 - C1Q alkilowe, C2 - C1Q alkenylowe, C^ - C10 alkinylowe lub C3 - C Q cyklo- alkilowe, przy czym kazda z tych grup moze byc ewentualnie podstawiona atomem chlorowca, grupe nitrowe, hydroksylowe, alkilowe, alkoksylowe, aryIowe lub aryloksylowe, podstawniki 2 6 R - R sa takie same lub rózne i oznaczaje atomy wodoru, atomy chlorowca, grupy C1 - C_ alkilowe, alkenylowe, alkinylowa lub alkoksylowe, przy czym kazda z tych grup moze byc e- wentualnia podstawiona jednym lub wieksze liczbe podstawników takich Jak atomy chlorowca, 2 6 grupy hydroksylowe 1 arylowa; badz R - R oznaczaje grupy aminowe, grupy ~NHR* lub -NR'r", w których R*i R** jednakowe lub rózne oznaczaje grupy C- 4 alkilowe, lub R - R oznaczaje grupy alkenyloksylowe, acylowe, acyloksylowe, cyjanowe, nitrowe, arylowe i alkilotio, bedz 2 6 dowolne dwa sesiednie podstawniki sposród podstawników R - R se poleczone ze sobe i two¬ rze grupe o wzorze -CH-CH-CH»CH-, oraz ich tautomerów 5-iminowych i soli, znamien- 2 6 n y tym, ze zwiazek o wzorze 7 lub 7a, w którym podstawniki R - R maje wyzej poda¬ ne znaczenie, poddaje sie reakcji ze zwiezkiem o wzorze Q - R , w którym Q oznacza grupe opuszczajece take jak atom chlorowca lub pochodne kwasu sulfonowego, a R ma wyzej podane znaczenie, i ewentualnie otrzymane zwiezki przeksztalca sie w sole.
2. Sposób wedlug zastrz. 1, znamienny tym, ze stosuje sie reagent, w którego wzorze R oznacza grupe metylowe, n-propylowe lub izopropylowe, a Q ma znaczenie podana powyzej•
3. Sposób wedlug zastrz. 1, znamienny tym, ze stosuje sie substrat, 2 6 w którym R - R maje znaczenie podane powyzej, przy czym calkowita liczba atomów w podstaw- 2 6 nikach R - R wynosi mniej niz 6.
4. Sposób wedlug zastrz. 1, znamienny tym, ze otrzymany zwiezek o wzorze 6, w którym R - R maje wyzej podane znaczenie przeksztalca sie w metanosulfonian lub chlorowodorek.144 899 Y «^. II iAlzOrl Wzór 3 R1 Wzór 2 R1! m ,R'2 R1 HN^N- WztfrS144899 HN^N NH; Wzór Ga Wzór? Pracownia Poligraficzna UP PRL. Naklad 100 egz. Cena 220 zl PL PL PL PL
PL1984250213A 1983-10-27 1984-10-26 Method of obtaining novel triazine derivatives PL144899B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds

Publications (2)

Publication Number Publication Date
PL250213A1 PL250213A1 (en) 1985-12-03
PL144899B1 true PL144899B1 (en) 1988-07-30

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1984250213A PL144899B1 (en) 1983-10-27 1984-10-26 Method of obtaining novel triazine derivatives

Country Status (21)

Country Link
US (1) US4649139A (pl)
EP (1) EP0142306A3 (pl)
JP (1) JPS60109577A (pl)
KR (1) KR890000991B1 (pl)
AU (1) AU564667B2 (pl)
CA (1) CA1261328A (pl)
DD (1) DD224033A5 (pl)
DK (1) DK512184A (pl)
ES (1) ES8606304A1 (pl)
FI (1) FI844212L (pl)
GB (1) GB8328757D0 (pl)
GR (1) GR80723B (pl)
HU (1) HU191566B (pl)
IL (1) IL73332A (pl)
MC (1) MC1628A1 (pl)
NZ (1) NZ210000A (pl)
PH (1) PH21926A (pl)
PL (1) PL144899B1 (pl)
PT (1) PT79416B (pl)
SU (1) SU1371500A3 (pl)
ZA (1) ZA848388B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
GB0800741D0 (en) 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
GB2471729A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471713A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US10576086B2 (en) 2015-06-12 2020-03-03 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
US4649139A (en) 1987-03-10
GB8328757D0 (en) 1983-11-30
GR80723B (en) 1985-02-07
NZ210000A (en) 1987-08-31
PT79416B (en) 1986-11-13
ES537104A0 (es) 1986-04-16
PL250213A1 (en) 1985-12-03
ES8606304A1 (es) 1986-04-16
DK512184D0 (da) 1984-10-26
FI844212A0 (fi) 1984-10-26
EP0142306A2 (en) 1985-05-22
AU564667B2 (en) 1987-08-20
DD224033A5 (de) 1985-06-26
IL73332A0 (en) 1985-01-31
HU191566B (en) 1987-03-30
FI844212L (fi) 1985-04-28
PT79416A (en) 1984-11-01
EP0142306A3 (en) 1986-11-20
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
ZA848388B (en) 1986-06-25
PH21926A (en) 1988-04-08
DK512184A (da) 1985-04-28
KR890000991B1 (ko) 1989-04-15
KR850002964A (ko) 1985-05-28
CA1261328A (en) 1989-09-26
HUT36102A (en) 1985-08-28
IL73332A (en) 1988-06-30
AU3475884A (en) 1985-05-09
SU1371500A3 (ru) 1988-01-30

Similar Documents

Publication Publication Date Title
PL144899B1 (en) Method of obtaining novel triazine derivatives
Young et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
HU913052D0 (en) Heterocyclic compounds
CA2274594A1 (en) Aminopyrazole derivatives
NO20051051L (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
YU44998A (sh) Pirazolska jedinjenja, postupci za njihovu proizvodnju i herbicidi koji ih sadrže
RU99107290A (ru) Производные 1,2,3,4-тетрагидробензофуро[3,2-c]пиридина
Iwamura et al. Quantitative Structure-Activity Relationships in Cytokinin Agonistic and Antagonistic Pyrido [2, 3-d] pyrimidine Derivates: Insights into Receptor Topology
NZ337840A (en) Processes for preparing pesticidal intermediates to 2-arylhydrazonosuccinonitrile compounds and 2-arylhydrazinosuccinonitrile compounds
BR0213172A (pt) Amida do ácido 8-amino-[1,2,4]triazolo[1,5-a]piridina-6-carboxìlico
KR950025039A (ko) 신규의 치환된 피리딘 이미다졸 유도체 및 그의 제조방법
KR930703269A (ko) 술포닐우레아 유도체, 그의 제조 방법 및 용도
IE872774L (en) Imidazoles
GB907646A (en) Method of production of new derivatives of diazepin
JPH08504481A (ja) 水性−酸性ニッケル電気めっき浴用光沢剤としてのチウロニウム塩の使用
IL44292A (en) Preparation of 2-aminoindane derivatives
PL90457B1 (en) Benzimidazole derivatives[US3941788A]
CA2346084A1 (en) Benzothieno[3,2-c]pyridines as .alpha.2 antagonists
DE69016672D1 (de) 4-(hetero)arylmethyloxy-phenyl-diazolderivate, verfahren zu deren herstellung und ihre therapeutische verwendung.
US3622608A (en) Nitro anilino-polyalkylene polyamines and the salts thereof
GB2052476A (en) Quaternized-polyamines
HUP0104045A2 (hu) Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
JPH07503282A (ja) ニッケル鍍金成形部材の製法
PL134228B1 (en) Bath for electroplating of bright copper coatings